DEGRONIMID Trademark

Trademark Overview

On Wednesday, November 18, 2015, a trademark application was filed for DEGRONIMID with the United States Patent and Trademark Office. The USPTO has given the DEGRONIMID trademark a serial number of 86824767. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 22, 2019. This trademark is owned by C4 Therapeutics, Inc.. The DEGRONIMID trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, targeted preparations that degrade disease-causing proteins
degronimid

General Information

Serial Number86824767
Word MarkDEGRONIMID
Filing DateWednesday, November 18, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 22, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 26, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, targeted preparations that degrade disease-causing proteins

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 23, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameC4 Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameC4 Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMcLean, VA 22101

Trademark Events

Event DateEvent Description
Monday, July 22, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 22, 2019ABANDONMENT - NO USE STATEMENT FILED
Friday, December 14, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 13, 2018EXTENSION 5 GRANTED
Wednesday, December 5, 2018EXTENSION 5 FILED
Thursday, December 13, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 5, 2018TEAS EXTENSION RECEIVED
Tuesday, May 29, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 25, 2018EXTENSION 4 GRANTED
Friday, May 25, 2018EXTENSION 4 FILED
Friday, May 25, 2018TEAS EXTENSION RECEIVED
Thursday, December 14, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 12, 2017EXTENSION 3 GRANTED
Tuesday, December 12, 2017EXTENSION 3 FILED
Tuesday, December 12, 2017TEAS EXTENSION RECEIVED
Thursday, December 7, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 7, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, April 29, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 27, 2017EXTENSION 2 GRANTED
Thursday, April 27, 2017EXTENSION 2 FILED
Thursday, April 27, 2017TEAS EXTENSION RECEIVED
Wednesday, December 7, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 5, 2016EXTENSION 1 GRANTED
Monday, December 5, 2016EXTENSION 1 FILED
Monday, December 5, 2016TEAS EXTENSION RECEIVED
Wednesday, November 30, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 30, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 21, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 26, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 26, 2016PUBLISHED FOR OPPOSITION
Wednesday, April 6, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 11, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 10, 2016ASSIGNED TO EXAMINER
Monday, November 23, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, November 21, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

degronimid preparations causing proteins disease targeted namely pharmaceutical degrade